Drug Error Reporting Form
Contents |
error or hazard to ISMP. If you are a CONSUMER, please click on the orange button below if you are ready to report an error or adverse drug reporting form hazard. If you are a HEALTHCARE PRACTITIONER, you can report the error or medication error reporting form (pdf) hazard to ISMP using one of two secure methods: 1) Report to the ISMP National Medication Errors Reporting Program (MERP) pharmacy error reporting form or the ISMP National Vaccine Errors Reporting Program (VERP) These are confidential, voluntary reporting programs operated by ISMP to learn about the causes of medication and vaccine errors. After you submit a report, medication error report form template ISMP staff will follow up with you to ask additional questions to clarify what went wrong and to identify the causes and factors that contributed to the reported event. The report will also be forwarded in confidence to the US Food and Drug Administration (FDA) and, when applicable, to product vendors to inform them about pharmaceutical labeling, packaging, and nomenclature issues that may cause errors by their
Medication Error Reporting Format
design. Your name, contact information, and location will NOT be submitted to FDA or product vendors without your permission, and identifiable information will NOT be disclosed outside of ISMP. Click on the appropriate button below if you are ready to report an error or hazard to the ISMP MERP or ISMP VERP. Click here to learn more about ISMP reporting programs. 2) Report an adverse event to ISMP as a Patient Safety Organization (PSO) You may prefer to report an adverse medication or vaccine event to ISMP as a federally certified Patient Safety Organization (PSO). As a PSO, federal legal protection can be provided for certain patient safety information prepared within your patient safety evaluation system and submitted to ISMP. The protected information, called patient safety work product, includes information you provide about why the error happened or why the hazard exists, along with any further analysis of the event provided back to you by ISMP. The basic facts, whether written or observed, regarding what happened along with the patient’s medical/health records, are NOT considered patient safety work product and cannot be provided with federal protection in the event of a lawsuit. However, contextually identifiable inf
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug Safety
Medication Error Reporting Procedure
and Availability Medication Errors Medication Errors Related to Drugs Share Tweet Linkedin Pin medication error reporting categories it More sharing options Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the medication error reporting and prevention Division of Medication Error Prevention and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council for Medication https://www.ismp.org/orderforms/reporterrortoismp.asp Error Reporting and Prevention (NCCMERP) definition of a medication error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product http://www.fda.gov/drugs/drugsafety/medicationerrors/ labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to address safety issues resulting from the name confusion